Vanguard Capital Management
AGIO icon

Vanguard Capital Management’s Agios Pharmaceuticals AGIO Stock Holding History

Vanguard Capital Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$99.5M Buy
2,681,845
+49,529
+2% +$1.5M ﹤0.01% 1555
2026
Q1 		$89.1M Buy
+2,632,316
New +$74.6M ﹤0.01% 1535

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Capital Management's AGIO Position: Q2 2026 in Review

Vanguard Capital Management increased its Agios Pharmaceuticals (AGIO) stake by 1.9% in Q2 2026, buying an estimated $1.5M and bringing the position to 2,681,845 shares worth $99.5M. The position accounts for ﹤0.01% of the portfolio, ranked #1555.

Vanguard Capital Management first reported a position in AGIO in Q1 2026 and has held it in 2 quarters since. 236 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Vanguard Capital Management held 2,681,845 shares of Agios Pharmaceuticals worth $99.5M as of Q2 2026.
  • Vanguard Capital Management bought 49,529 Agios Pharmaceuticals shares in Q2 2026, an estimated $1.5M.
  • Agios Pharmaceuticals made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #1555 holding.
  • Vanguard Capital Management first reported a position in Agios Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 236 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.